Spontaneous and risk period–related VTE according to age group
Age group . | 0-4 y . | 5-8 y . | 9-13 y . | 14-18 y . |
---|---|---|---|---|
No. of subjects | 6 | 11 | 19 | 60 |
Overall VTE | 1 | 1 | 0 | 4 |
AI, 12.5 (95% CI, 0.32-69.6) | AI, 3.2 (95% CI, 0.82-18) | AI, 0 (95% CI, 0-6.2) | AI, 2.1 (95% CI, 0.6-5.4) | |
Spontaneous VTE | 1 | 0 | 0 | 1 |
AI, 12.5 (95% CI, 0.32-69.6) | AI, 0 (95% CI, 0-12) | AI, 0 (95% CI, 0-6.2) | AI, 0.53 (95% CI, 0.013-2.9 | |
Risk period–related VTE | 0 | 1 | 0 | 3 |
0% per risk period (95% CI, 0-369) | 25% per risk period (95% CI, 0.63-139) | 0% per risk period (95% CI, 0-74) | 50% per risk period (95% CI, 10.3-146) | |
1 lung infection | 3 traumas | 1 operation | 1 operation | |
1 CVL | 4 traumas | 3 traumas* | ||
2 OCT |
Age group . | 0-4 y . | 5-8 y . | 9-13 y . | 14-18 y . |
---|---|---|---|---|
No. of subjects | 6 | 11 | 19 | 60 |
Overall VTE | 1 | 1 | 0 | 4 |
AI, 12.5 (95% CI, 0.32-69.6) | AI, 3.2 (95% CI, 0.82-18) | AI, 0 (95% CI, 0-6.2) | AI, 2.1 (95% CI, 0.6-5.4) | |
Spontaneous VTE | 1 | 0 | 0 | 1 |
AI, 12.5 (95% CI, 0.32-69.6) | AI, 0 (95% CI, 0-12) | AI, 0 (95% CI, 0-6.2) | AI, 0.53 (95% CI, 0.013-2.9 | |
Risk period–related VTE | 0 | 1 | 0 | 3 |
0% per risk period (95% CI, 0-369) | 25% per risk period (95% CI, 0.63-139) | 0% per risk period (95% CI, 0-74) | 50% per risk period (95% CI, 10.3-146) | |
1 lung infection | 3 traumas | 1 operation | 1 operation | |
1 CVL | 4 traumas | 3 traumas* | ||
2 OCT |
Patients contributed to multiple age groups.
One with prophylaxis.